+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8azy | ||||||
|---|---|---|---|---|---|---|---|
| Title | KRAS-G12D in complex with BI-2865 | ||||||
Components | GTPase KRas | ||||||
Keywords | ONCOPROTEIN / Inhibitor / Complex / GTPase | ||||||
| Function / homology | Function and homology informationresponse to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation ...response to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation / Rac protein signal transduction / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / myoblast proliferation / skeletal muscle cell differentiation / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / positive regulation of glial cell proliferation / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / cardiac muscle cell proliferation / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Estrogen-stimulated signaling through PRKCZ / glial cell proliferation / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / FRS-mediated FGFR1 signaling / p38MAPK events / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / striated muscle cell differentiation / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / homeostasis of number of cells within a tissue / Downstream signal transduction / GRB2 events in ERBB2 signaling / Insulin receptor signalling cascade / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / response to glucocorticoid / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / small monomeric GTPase / FCERI mediated MAPK activation / liver development / female pregnancy / RAF activation / Signaling by ERBB2 TMD/JMD mutants / Signaling by SCF-KIT / Constitutive Signaling by EGFRvIII / Signaling by high-kinase activity BRAF mutants / regulation of long-term neuronal synaptic plasticity / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / visual learning / Signaling by ERBB2 KD Mutants / cytoplasmic side of plasma membrane / cytokine-mediated signaling pathway / Regulation of RAS by GAPs / Signaling by CSF1 (M-CSF) in myeloid cells / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / Signaling by BRAF and RAF1 fusions / positive regulation of cellular senescence / DAP12 signaling / MAPK cascade / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.09 Å | ||||||
Authors | Boettcher, J. / Herdeis, L. | ||||||
| Funding support | Austria, 1items
| ||||||
Citation | Journal: Nature / Year: 2023Title: Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Authors: Kim, D. / Herdeis, L. / Rudolph, D. / Zhao, Y. / Bottcher, J. / Vides, A. / Ayala-Santos, C.I. / Pourfarjam, Y. / Cuevas-Navarro, A. / Xue, J.Y. / Mantoulidis, A. / Broker, J. / Wunberg, T. ...Authors: Kim, D. / Herdeis, L. / Rudolph, D. / Zhao, Y. / Bottcher, J. / Vides, A. / Ayala-Santos, C.I. / Pourfarjam, Y. / Cuevas-Navarro, A. / Xue, J.Y. / Mantoulidis, A. / Broker, J. / Wunberg, T. / Schaaf, O. / Popow, J. / Wolkerstorfer, B. / Kropatsch, K.G. / Qu, R. / de Stanchina, E. / Sang, B. / Li, C. / McConnell, D.B. / Kraut, N. / Lito, P. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8azy.cif.gz | 153.2 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8azy.ent.gz | 100.6 KB | Display | PDB format |
| PDBx/mmJSON format | 8azy.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/az/8azy ftp://data.pdbj.org/pub/pdb/validation_reports/az/8azy | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 8azrC ![]() 8azvC ![]() 8azxC ![]() 8azzC ![]() 8b00C ![]() 8onvC ![]() 8afbS C: citing same article ( S: Starting model for refinement |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||||
| Unit cell |
|
-
Components
-Protein , 1 types, 1 molecules A
| #1: Protein | Mass: 19370.781 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: ![]() |
|---|
-Non-polymers , 5 types, 227 molecules 








| #2: Chemical | ChemComp-GDP / | ||||
|---|---|---|---|---|---|
| #3: Chemical | ChemComp-MG / | ||||
| #4: Chemical | ChemComp-EDO / #5: Chemical | ChemComp-OFU / ( | #6: Water | ChemComp-HOH / | |
-Details
| Has ligand of interest | Y |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.55 Å3/Da / Density % sol: 51.79 % |
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, hanging drop Details: 0.2mM Magnesium Chloride, 20% PEG 2000, 100mM sodium acetate pH 4.4 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SLS / Beamline: X06SA / Wavelength: 1.000004 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Mar 18, 2022 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.000004 Å / Relative weight: 1 |
| Reflection | Resolution: 1.09→36.762 Å / Num. obs: 57094 / % possible obs: 94.9 % / Redundancy: 12.2 % / Biso Wilson estimate: 12.44 Å2 / Rmerge(I) obs: 0.055 / Rsym value: 0.055 / Net I/σ(I): 17.7 |
| Reflection shell | Resolution: 1.094→1.206 Å / Redundancy: 10.3 % / Rmerge(I) obs: 1.192 / Mean I/σ(I) obs: 1.8 / Num. unique obs: 2856 / Rsym value: 1.192 / % possible all: 75.8 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 8AFB Resolution: 1.09→36.76 Å / SU ML: 0.0899 / Cross valid method: FREE R-VALUE / σ(F): 1.35 / Phase error: 24.1122 Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 20.48 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.09→36.76 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
X-RAY DIFFRACTION
Austria, 1items
Citation






PDBj




















